2m 2m 2m 2m 2m 2m 2m
- N/AMarket Cap
- 1.00%1-Year Change
- N/AIndustry
Micro Imaging Te (MMTC)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
Micro Imaging Technology is pleased to Announce the Acquisition of Cellmyx
Micro Imaging Technology, Inc. (MMTC) announced the acquisition of Cellmyx, a 25-year-old manufacturer of medical tools for aesthetic, cosmetic surgery, and regenerative medicine. The acquisition complements MIT's previous acquisition of SaltMed/SaltFacial and strengthens the company's ability to expand and manufacture products nationally and worldwide. Cellmyx specializes in autologous adipose grafting and holds FDA clearance for its intelliFat® BOD™ technology for orthopedic and cosmetic procedures.
06/05/2026, 8:45 AM • Benzinga
Peers
Statistics
MoreInformation as of 05/15/2026
Company Profile
Micro Imaging Technology, Inc. engages in the development of fluid monitoring systems for food safety and clinical industries in the United States. The company is developing a laser-based rapid microbial identification system capable of identifying pathogenic bacteria. The company has a collaboration Northern Michigan University to investigate an alternative pathogen sample preparation method that could provide a specimen test turnaround time of 4 to 5 hours. The company was formerly known as Electropure, Inc. and changed its name to Micro Imaging Technology, Inc. in November 2005. Micro Imaging Technology, Inc. was incorporated in 1979 and is headquartered in San Clemente, California.
Key Executives
- Victor A. Hollander
- David L. Haavig
Current Ownership Distribution
- Other9.0M (100.00%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)
- Insiders0 (0.00%)